Biocytogen Pharmaceuticals (beijing) Co. Ltd. Class ASSE: 688796

Announcement on Convening Performance Briefing for 2025 and Q1 2026

· Issued by Biocytogen Pharmaceuticals (beijing) Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening Performance Briefing for 2025 and Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Biocytogen Pharmaceuticals (beijing) Co. Ltd. Class A

All Biocytogen Pharmaceuticals (beijing) Co. Ltd. Class A news releases